Glucose transporter 3 is a rab11-dependent trafficking cargo and its transport to the cell surface is reduced in neurons of CAG140 Huntington’s disease mice by McClory, Hollis et al.
 
Glucose transporter 3 is a rab11-dependent trafficking cargo and
its transport to the cell surface is reduced in neurons of CAG140
Huntington’s disease mice
 
 
(Article begins on next page)
The Harvard community has made this article openly available.
Please share how this access benefits you. Your story matters.
Citation McClory, Hollis, Dana Williams, Ellen Sapp, Leah W Gatune,
Ping Wang, Marian DiFiglia, and Xueyi Li. 2014. “Glucose
transporter 3 is a rab11-dependent trafficking cargo and its
transport to the cell surface is reduced in neurons of CAG140
Huntington’s disease mice.” Acta Neuropathologica
Communications 2 (1): 179. doi:10.1186/s40478-014-0178-7.
http://dx.doi.org/10.1186/s40478-014-0178-7.
Published Version doi:10.1186/s40478-014-0178-7
Accessed February 17, 2015 11:39:01 AM EST
Citable Link http://nrs.harvard.edu/urn-3:HUL.InstRepos:13890720
Terms of Use This article was downloaded from Harvard University's DASH
repository, and is made available under the terms and conditions
applicable to Other Posted Material, as set forth at
http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-
of-use#LAARESEARCH Open Access
Glucose transporter 3 is a rab11-dependent
trafficking cargo and its transport to the cell
surface is reduced in neurons of CAG140
Huntington’sd i s e a s em i c e
Hollis McClory
1, Dana Williams
1, Ellen Sapp
1, Leah W Gatune
1, Ping Wang
2, Marian DiFiglia
1 and Xueyi Li
1*
Abstract
Huntington’s disease (HD) disturbs glucose metabolism in the brain by poorly understood mechanisms. HD
neurons have defective glucose uptake, which is attenuated upon enhancing rab11 activity. Rab11 regulates
numerous receptors and transporters trafficking onto cell surfaces; its diminished activity in HD cells affects the recycling
of transferrin receptor and neuronal glutamate/cysteine transporter EAAC1. Glucose transporter 3 (Glut3) handles most
glucose uptake in neurons. Here we investigated rab11 involvement in Glut3 trafficking. Glut3 was localized to rab11
positive puncta in primary neurons and immortalized striatal cells by immunofluorescence labeling and detected in
rab11-enriched endosomes immuno-isolated from mouse brain by Western blot. Expression of dominant active and
negative rab11 mutants in clonal striatal cells altered the levels of cell surface Glut3 suggesting a regulation by rab11.
About 4% of total Glut3 occurred at the cell surface of primary WT neurons. HD
140Q/140Q neurons had significantly less
cell surface Glut3 than did WT neurons. Western blot analysis revealed comparable levels of Glut3 in the striatum and
cortex of WT and HD
140Q/140Q mice. However, brain slices immunolabeled with an antibody recognizing an extracellular
epitope to Glut3 showed reduced surface expression of Glut3 in the striatum and cortex of HD
140Q/140Q mice compared
to that of WT mice. Surface labeling of GABAα1 receptor, which is not dependent on rab11, was not different between
WT and HD
140Q/140Q mouse brain slices. These data define Glut3 to be a rab11-dependent trafficking cargo and suggest
that impaired Glut3 trafficking arising from rab11 dysfunction underlies the glucose hypometabolism observed in HD.
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Introduction
Huntington’s disease (HD) is a progressive neurodegen-
erative disorder caused by a mutation in huntingtin
(Htt) [1]. How mutant Htt leads to neurodegeneration is
still under investigation, but may involve defects associ-
ated with multiple pathways [2]. Positron emission tom-
ography brain imaging with [
18F]-fluorodeoxyglucose
has revealed a regional decrease of glucose usage in the
striatum (caudate and putamen) and cortex (frontal and
temporal lobes) of persons symptomatic and at risk for
HD [3-8]. Decreased activity of brain glucose metabol-
ism correlates with the progression of HD [9]. However,
the mechanism underlying reduced glucose usage is
poorly understood.
Glucose is a polar molecule; its transport across
plasma membranes is facilitated largely via the SLC2
family of 13 glucose transporters (Glut). Brain tissues
express 8 Glut isoforms, two of which, namely Glut1
and Glut3, are believed to handle the majority of glucose
uptake in the brain [10-12]. Glut1 is present in vascular
structures across all brain areas including the white mat-
ter and localized selectively to astrocytes and microves-
sel endothelial cells [13,14]. Glut3, on the other hand, is
expressed in neurons in all layers of neocortex, the stri-
atum, the thalamus, midbrain, cerebellum and the epen-
dymal layer of all ventricles [14-16]. In the brain and in
cultured neurons, Glut3 protein is detected in somata
and neural processes [12,15]. HD patients at early stages
of striatal degeneration (grade I [17]) have normal levels of
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the brain [3,8,18]. This suggests that reduced glucose
utilization in early stages of HD is unlikely to result from
altered expression of Glut3 protein.
Rab11 is a ras-like GTPase that plays a pivotal role in
sustaining the homeostatic abundance of receptors,
transporters and other critical molecules on the cell sur-
face by regulating vesicle formation at the recycling en-
dosome, vesicle transport along cytoskeleton networks,
and vesicle fusion with the plasma membrane [19-22].
The HD mutation is known to reduce the production of
active rab11, thereby slowing endosomal recycling of re-
ceptors and transporters to the cell surface [23-26]. In a
previous study we showed that primary HD
140Q/140Q
cortical neurons have a deficit in taking up glucose,
which can be attenuated upon expression of active rab11
[25]. In this study, we addressed if Glut3 trafficking is reg-
ulated by rab11 and if there is a deficit of Glut3 trafficking
in HD neurons. We found Glut3 co-distributed with rab11
and present in immuno-isolated brain rab11 enriched
endosomes. Glut3 expression on the cell surface of immor-
talized striatal cells was altered upon expressing mutant
forms of rab11. Analysis of the surface expression of Glut3
by biotin labeling and immunostaining with an antibody
recognizing an extracellular epitope of Glut3 showed that
expression of the transporter on the cell surface was
reduced in cultured HD
140Q/140Q neurons and in adult
HD
140Q/140Q mouse brain neurons respectively compared
to WT. Our study suggests that defective Glut3 trafficking
arising from compromised activation of rab11 in HD
neurons contributes to glucose hypometabolism in HD.
Materials and methods
Preparation and culture of primary cortical neurons
Homozygous Q140 knock-in HD (HD
140Q/140Q)a n dW T
mice were maintained and bred at the Animal Core Facil-
ity of the Massachusetts General Hospital. Experiments
involved in the use of mice were performed according to
the institutional and US National Institute of Health
guidelines and approved by the Massachusetts General
Hospital Subcommittee on Research Animal Care. Neu-
rons from embryonic cortex of mice were isolated and cul-
tured as described previously [25]. In brief, embryos were
h a r v e s t e da te m b r y o n i cd a y1 6t o1 8( E 1 6-E 1 8 ) .C o r t i c e s
were dissected free of meninges and other connective
tissues, pooled and incubated in PBS supplemented with
penicillin, streptomycin, neomycin, and 0.25% trypsin in a
37°C cell culture incubator for 10 min. Cells released from
cortices were washed twice in PBS with calcium and mag-
nesium, and resuspended in NBM media (Neurobasal
DMEM containing B27 supplement, N2 supplement,
25 mM mercaptoethanol and L-glutamine), and cultured
in poly-L-lysine coated dishes (BD Biosciences). After cul-
ture for 24 to 48 hours, primary cells were treated with
cytosine arabinoside for 24 hours, then changed into fresh
NBM media, and cultured in a 37°C cell culture incubator
until used for analysis.
Biotinylation assay
Biotinylation of cell surface proteins was performed as
described [26]. Immortalized striatal (STHdhQ7/Q7 and
STHdhQ111/Q111) cells were obtained from Coriell and
cultured as described [27]. For studying rab11-dependent
trafficking of Glut3, STHdhQ7/Q7 were infected with
lentivirus expressing permanently active or inactive rab11
for two days and then processed for biotinylation. After
biotinylation, cells were washed 3 times in cold 0.1 M Tris/
HCl (pH8.0) and scraped into lysis buffer (50 mM Tris/
HCl, pH7.4, 150 mM NaCl, 1 mM EDTA, 1% TX-100, and
protease inhibitors). Post-nuclear supernatants were incu-
bated with Streptavidin agarose (Pierce). Cell surface pro-
teins (biotinylated) bound on Streptavidin agarose were
washed and eluted into SDS-PAGE sample buffer for West-
ern blot analysis. Unbiotinylated (intracellular) proteins in
the supernatants were precipitated and resuspended in
SDS-PAGE sample buffer for Western blot analysis.
Immunofluorescence microscopy
Cells on glass coverslips were fixed in 4% paraformalde-
hyde. After incubation in 50 mM NH4Cl containing
0.1% Triton X-100, cells on coverslips were washed,
blocked in PBS containing 1% BSA and 0.05% Tween 20,
and incubated with antibodies against Glut3 (1: 100,
Abcam) and rab11 (1: 100, BD Biosciences) followed by
incubation with secondary antibodies conjugated with
BODIPY FL (Invitrogen), Cy-3 (Jackson Laboratories) and
Hoechst 33258 (Invitrogen). Immunofluorescence micros-
copy was conducted using a 60×Oil Nikon Plan Apo
objective mounted on an inverted Nikon Eclipse TE300
fluorescent microscope. Images of each channel were
collected separately using the Bio-Rad 2100 LaserSharp
confocal system and merged using PhotoShop.
Digital confocal images of dual labeled neurons were
evaluated for the extent of co-localization of rab11 and
Glut3 using NIH ImageJ. Individual neurites from differ-
ent neurons with clear puncate labeling of the processes
were selected for analysis. The number of Glut3 labeled
puncta, rab11 labeled puncta and co-labeled puncta were
quantified in 20 neurite segments from 20 different neu-
rons. The mean percent± SD of co-labeled puncta were
expressed relative to the total Glut3 labeled puncta and
to the total rab11 labeled puncta, respectively.
Subcellular fractionation
Fresh brains of WT mice (3–6 months old) were minced
into pieces in 50 mM Tris/HCl, pH7.4, 150 mM NaCl,
1 mM EDTA containing 10% (w/v) sucrose and protease
inhibitors and homogenized by passing brain pieces
McClory et al. Acta Neuropathologica Communications  (2014) 2:179  Page 2 of 9through a dounce homogenizer for 12 to 15 strokes on
ice. Post-nuclear supernatants were supplemented with
60% (w/v) sucrose to a final concentration of 40% (w/v),
placed in a SW41 ultracentrifuge tube (Beckman-Coulter),
and overlaid with a 10 - 40% (w/v) continuous sucrose
gradient. After centrifugation of the gradients at 4°C
100,000 × g for 24 hours, 12 fractions (1 ml each) were
collected from the top of the gradient. Equal volumes of
each fraction were used for Western blot analysis.
To isolate rab11 positive organelles, brain fractions
enriched with rab11 (fraction-5) were diluted in detergent-
free immunoprecipitation buffer (final concentration:
25 mM Tris/HCl, pH7.4, 133 mM KCl, 1 mM EDTA,
pH7.1) and incubated with antibodies specific for rab11 or
FLAG pre-immobilized on protein-A resins. After washes
in the detergent-free immunoprecipitation buffer, proteins
bound onto protein-A resins were eluted in SDS-PAGE
sample buffer and analyzed by SDS-PAGE and Western
blot using antibodies against Glut3.
SDS-PAGE and Western blot
SDS-PAGE and Western blot analysis were performed
as described previously [28]. We noticed that Glut3
signals occurred as high molecular weight smears when
samples were boiled, and therefore we incubated sam-
ples at room temperature for 30 minutes. Protein blotting
was performed using the iBlot system (Invitrogen). The
blots were blocked in PBS containing 5% nonfat milk and
0.05% Tween-20 and incubated with antibodies against
Glut3 (1:500; Abcam) and/or actin (1:500; Sigma-Aldrich)
followed by detection with peroxidase-conjugated second-
ary antibodies (1:5,000; Jackson ImmunoResearch Labora-
tories). Blots were developed using enhanced ECL
(Pierce). Films were scanned. Densitometry was performed
on the digitized images using NIH ImageJ.
Immunohistochemistry detection of cell surface proteins
in brain slices and quantitative analysis
A series of coronal sections of 50 μm were cut through
the striatum with a vibratome and processed for immu-
nohistochemistry using the immunoperoxidase method.
Detergents were absent in all solutions used for labeling
and washes to prevent the entrance of antibodies into
cells. Brain sections were blocked with 5% donkey
serum, 1% bovine serum albumin, and 0.03% hydrogen
peroxide in PBS and incubated with goat anti-Glut3
antibodies (I-14, Santa Cruz Biotechnology) or rabbit
anti-GABAα1 antibodies (Alomone Labs) at 4°C for two
days followed by incubation with biotinylated anti-goat
or anti-rabbit IgG(H + L) at 4°C overnight. Brain sections
were incubated with ABC reagents (Vector Laboratories,
Inc.) at room temperature for 90 minutes followed by
DAB staining for 2 minutes. After washes in water, brain
sections were mounted on glass slides in 0.5% gelatin
and 30% ethanol, and air-dried overnight. After dehydra-
tion, brain sections on glass slides were examined and
images were collected using a SPOT camera.
Digital images were analyzed using NIH ImageJ by an
examiner who was blinded to the conditions. All images
were analyzed in the same manner. Glut3 and GABAα1
labeling on cell surfaces was quantified as signal intensity
measured using NIH ImageJ. The background was sub-
tracted using a rolling ball radius of 50.0 pixels. The
threshold was set with a dark background. The back-
ground threshold was set the same for each image ana-
lyzed. In some cases, the area to be measured was circled
to remove excess staining at the edge of the section. The
entire selected area was measured using the “Analyze Par-
ticles” Plugin. For neuronal size, the cross-sectional area
of each cell was measured using NIH ImageJ. The arbi-
trary units (A.U.) of signal intensities or cross-sectional
Figure 1 Impaired trafficking of Glut3 to cell surfaces in primary HD
140Q/140Qneurons. Primary neurons at DIV8 were used for studies.
A) Western blot analysis of biotinylated cell surface proteins and corresponding post-nuclear supernatants of WT and HD cortical neurons.
Shown is one blot analysis of three experiments. B) Densitometry. Intensities of signals for biotinylated Glut3 (cell surface) and for total Glut3
in post-nuclear supernatants were measured using NIH ImageJ. The ratio of biotinylated Glut3 to total Glut3 was used for calculating the
percentage of WT, which was set as 100%. Mean±SD percentage of WT was graphed (n=3 experiments, Student’ t-test: * p<0.05). C) Western blot
shows distribution of Glut3 compared to that of NCAM, a protein known to locate mainly on the neuronal cell surface, and to that of actin, which is
predominantly intracellular. Shown is one of 3 sets of analysis of Glut3, NCAM and actin distribution in primary WT cortical neurons. All of the aqueous
solution eluted from the Streptavidin beads and 30% of unbiotinylated proteins were used for Western blot analysis.
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Mean±SD signal intensity per cell or Mean±SD cross-
sectional area of each cell.
Results
Defective trafficking of Glut3 to cell surfaces in primary
HD neurons
We previously showed that primary neurons cultured
from embryonic cortex of HD
140Q/140Q mice took up sig-
nificantly less glucose than did primary neurons cultured
from WT mice [25]. Glut3 is believed to mediate the
majority of glucose uptake in neurons. However, the glu-
cose uptake defect in HD
140Q/140Q neurons was unlikely
to result from aberrant expression of Glut3 protein be-
cause the overall levels of Glut3 protein in primary
HD
140Q/140Q neurons were comparable to those in WT
neurons (Figure 1A). To examine if Glut3 trafficking to
cell surfaces was altered in neurons of HD
140Q/140Q mice,
we performed a biotinylation assay to analyze cell surface
and intracellular pools of Glut3 in primary neurons. We
found that the signal for biotinylated Glut3 was extremely
low in both WTand HD
140Q/140Q neurons, and was hardly
detected in some experiments (Figure 1A and data not
shown). This result was consistent with findings by Ferreria
and colleagues [29]. Densitometrical analysis of results
from three experiments with detectable biotinylated Glut3
signals in both WT and HD
140Q/140Q neurons showed that
signals for biotinylated Glut3 in HD neurons were reduced
by 31.8± 14.62% relative to biotinylated Glut3 signals in
WT neurons (n =3 experiments, Mean±SD, two-tailed
Student t-test: p<0.05; Figure 1B). As controls in the bio-
tinylation assay we analyzed neural cell adhesion molecule
(NCAM), a cell surface marker of neurons, and actin, a
cytoskeletal protein located inside cells, As expected,
the majority of NCAM molecules were biotinylated,
whereas actin was mainly unbiotinylated (Figure 1C),
indicating that cell surface proteins were efficiently
biotinylated. Densitometrical analysis revealed that 4.37±
2.58% of endogenous Glut3 was located on the cell surface
(n=3 experiments) in WT neurons. Together, these data
suggest that Glut3 trafficking to cell surfaces is impaired
in HD
140Q/140Q primary neurons.
Glut3 traffics through recycling endosomes
The low abundance of Glut3 on the cell surface is
reminiscent of many rab11-dependent trafficking cargo
proteins, e.g. transferrin receptor [30]. Therefore, we
examined if Glut3 traffics through rab11-positive
Figure 2 Glut3 is localized at rab11-positive endosomes. A), Co-localization of Glut3 and rab11 in primary cortical neurons. Primary WT
neurons on glass coverslips were processed for immunofluorescence labeling of endogenous Glut3 (red) and endogenous rab11 (green) analyzed
by confocal microscopy. Yellow areas in the merged photo show signals positive for both Glut3 and rab11. The boxed region containing part of
a neurite in each channel is enlarged and shown at the lower left corner of the corresponding channel. Arrowheads in enlarged photos indicate
co-localization of Glut3 and rab11. B), Co-distribution of Glut3 with rab11 in subcellular brain fractions. Density gradient ultracentrifugation was
conducted as described in Methods. Equal volume of each fraction was used for Western blot analysis. Shown is one blot analysis of three
experiments from three mice. C), Glut3 is present in organelles immuno-isolated from brain lysates using anti-rab11 antibodies. Fraction-5 from
(B) was diluted in detergent-free buffer and incubated with antibodies specific for rab11 or FLAG pre-immobilized on protein-A resins. After
washes in detergent-free buffer, proteins on protein-A resins were analyzed by Western blot with antibodies against Glut3. Shown is a Western
blot analysis from one of three experiments.
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were double labeled with antibodies for Glut3 and rab11
and confocal imaging analysis was performed as de-
scribed in methods. Immunoreactivity of endogenous
Glut3 and rab11 was seen in punctate structures in
neurites and somata (Figure 2A). Some structures were
immunoreative for both Glut3 and rab11 (Figure 2A).
Quantitative analysis revealed that 35.3 ±10.7% of Glut3
labeled puncta in the neurites also contained rab11, and
44.4 ±9.5% of rab11 positive puncta were also positive
for Glut3 (Mean ±SD, n =20 neurite segments from 20
different neurons).
We then performed subcellular fractionation of brain
lysates from 3–6 months old WT mice. Western blot
analysis showed that Glut3 signal was present in several
fractions and peaked in fraction-5, in which rab11 was also
enriched (Figure 2B). Immuno-isolation of organelles from
gradient fractions was used previously for validating the
co-localization of two proteins in the same organelle [31].
Therefore we isolated rab11-positive endosomes from
Figure 3 Rab11 regulates Glut3 trafficking. A) Defective glucose uptake in immortalized STHdhQ111/Q111 striatal cells. [
3H]deoxyglucose
uptake was performed in PBS at room temperature for 20 minutes. After uptake, cells were washed three times in cold PBS and cell lysates were
prepared. The amount of [
3H]deoxyglucose in cell lysates was measured by liquid scintillation. Mean±SD cpm per minute per milligram protein
was calculated and graphed (N=3, Two tailed Student t-test). B) Western blot analysis of post-nuclear supernatants showed up-regulated Glut3
protein expression in STHdhQ111/Q111 cells relative to STHdhQ7/Q7 cells. C) STHdhQ7/Q7 cells were cultured on glass coverslips, fixed and
processed for immunofluorescence labeling of endogenous Glut3 (green), endogenous rab11 (red), and nuclei (blue). The boxed region is
enlarged and shown at the lower left corner of the corresponding channel. Arrows in enlarged photos indicate structures containing both Glut3
and rab11. D) Western blot analysis of Glut3 levels upon expression of rab11 mutants. STHdhQ7/Q7 cells in 60-mm dishes were infected with
lentivirus expressing dNrab11, or virus expressing dArab11, or uninfected (No virus) for two days. Biotinylated proteins and corresponding total
cell lysates were analyzed by Western blot. The results from one of three experiments are shown. E) Densitometry of biotinylated Glut3 and
corresponding background signals in each condition using NIH ImageJ. The ratio of biotinylated Glut3 signal from cells infected with virus to
biotinylated Glut3 signal from cells with no virus infection was graphed (n =3 experiments, Mean± SD, Student t-test: *p< 0.05; **p <0.01).
F) Effects of dArab11 or dNrab11 on cell surface expression of Glut3 in STHdhQ111/Q111 cells. Experimental procedures and data analysis were
performed as in D). Shown are blot analysis from one of two experiments.
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in immuno-enriched organelles using anti-rab11 antibody
but not in immuno-enriched organelles isolated using
anti-FLAG antibody (control antibody) (Figure 2C). These
data indicate that Glut3 travels through rab11-positive
endosomes.
Rab11 modulates Glut3 trafficking to the cell surface
Having shown the presence of Glut3 at rab11 positive
endosomes, we next determined if rab11 regulates Glut3
trafficking. In consideration of technical difficulties to en-
rich biotinylated cell surface Glut3 from primary neurons,
we utilized immortalized striatal cells for investigating
rab11 involvement in Glut3 trafficking. Immortalized
STHdhQ7/Q7 and STHdhQ111/Q111 striatal cells, which
are established from WT and Q111 knock-in HD mouse
embryos, respectively [27], are easy to culture and can be
efficiently transfected with exogenous genes. Like primary
HD
140Q/140Q neurons [25], STHdhQ111/Q111 cells were
impaired in taking up glucose although total levels of Glut3
protein in STHdhQ111/Q111 cells were about 4.5-fold
higher than those in WT STHdhQ7/Q7 cells (Figure 3A
and B). In addition, immortalized striatal cells expressed
endogenous Glut3, which was co-localized with rab11 and
localized mainly inside of cells (Figure 3C). Hence,
these cells were excellent tools for studying the role of
rab11 in Glut3 trafficking. Dominant negative (dNrab11,
rab11S25N) and dominant active (dArab11, rab11Q70L)
forms of rab11 are widely used tools for manipulating the
function of rab11. We thus examined effects of expressing
these rab11 mutants on cell surface expression of Glut3 in
STHdhQ7/Q7 cells. Viral expression of either dNrab11 or
dArab11 did not affect overall levels of Glut3 protein in
STHdhQ7/Q7 cells (Figure 3D). However, levels of bio-
tinylated cell surface Glut3 were significantly increased in
cells expressing dArab11 and decreased in cells expressing
dNrab11 (Figure 3D and E). Similar effects of expressing
rab11 mutants on Glut3 trafficking were also observed in
STHdhQ111/Q111 cells (Figure 3F). Taken together, these
data indicate that Glut3 trafficking to the cell surface is
regulated by rab11.
Defective Glut3 trafficking in HD brain
Our above data showed no difference between WTand HD
primary neurons in Glut3 protein expression (Figure 1A).
We then performed Western blot analysis to determine
if overall levels of Glut3 protein expression were altered
in the brain of HD
140Q/140Q mice. The data in Figure 4
showed that HD
140Q/140Q mice at 9–10 months of age
expressed levels of Glut3 protein comparable to WT in
the cortex and the striatum, indicating that if the cell
surface expression of Glut3 was altered in the HD mouse
brain it was not a result of reduced overall levels of Glut3
protein expression. To examine if defective Glut3 traffick-
ing occurred in HD brain as it did in HD primary neurons,
we performed antibody-binding experiments in non-
permeabilized brain slices using antibodies specific for an
extracellular epitope of Glut3. We found that Glut3
immuno-reactive signals were significantly reduced by
about 11% in cortex and 15% in striatum of HD
140Q/140Q
brain slices relative to those in WT brain slices (Figure 5A
and B). There was also a significant decrease (about 15%)
in the cross-sectional area of the HD cortical and striatal
neurons compared to those of WT neurons (Figure 5C),
indicative of neuronal shrinkage in the HD mouse brain.
To determine if the reduced levels of Glut3 on the cell
surface of HD neurons was due to neuronal shrinkage or
rab11 dysfunction, we examined the surface expression of
another protein GABA type A receptor α1( G A B A α1),
which has been reported to traffic through a pathway that
is not dependent on rab11 [32]. The antibody-binding
assay to detect GABAα1e x p r e s s i o no nn e u r o n a lc e l ls u r -
faces was conducted in brain slices prepared from the
same mice used for detecting Glut3 expression. The cross
Figure 4 Normal levels of Glut3 protein in HD
140Q/140Q mouse brain. A) Western blot analysis of cortical and striatal lysates of 9–10 month
old WT and HD mice. Shown is a blot analysis from one of 6 WT and one of 6 HD mice. B) Intensities of signals for Glut3 and for GAPDH in each
condition were measured using NIH ImageJ and the ratio of Glut3 to GAPDH signals was calculated (n =6 WT and 6 HD mice, Mean±SD,
two-tailed Student’s t-test).
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significantly reduced by 27% in HD brain slices (Figure 5D
and E). However, the immuno-reactive signals for
GABAα1 at the cell surface were comparable in WT and
HD brain slices (Figure 5D and F). In the cortex of WT
and HD mice, no difference in overall levels of GABAα1
protein was revealed by Western blot assay (N=6 WT
and 6 HD cortex samples compared, data not shown).
Together these data indicate that Glut3 trafficking is
impaired in the HD mouse brain.
Discussion
Deficient energy metabolism is a hallmark in the pathogen-
esis of HD and may arise from multiple factors including
reduced glucose utilization in the brain. Studies in immor-
talized STHdhQ111/Q111 striatal cells suggest that energy
Figure 5 Defective Glut3 trafficking in the brain of adult HD
140Q/140Qmice. A) Antibody binding to detect cell surface Glut3 and GABAα1i n
non-permeabilized brain sections of 9–10 month old WT and HD mice. To ascertain that anti-Glut3 and anti-GABAα1 antibodies labeled only cell
surface molecules, we omitted detergents in all buffer solutions used for this assay to preserve the intactness of the plasma membrane. Anti-
bodies bound to cell surface Glut3 and GABAα1 were detected using the immunoperoxidase method. Shown in A are images of Glut3 labeling
obtained with a SPOT camera. Three WT and 3 age- and gender- matched HD mice were used for analysis. B) and C) Bar graphs show results of
densitometry of Glut3 labeled neurons in brain slices for Glut3 surface expression and neuronal cross-sectional area in the cortex and the striatum
of adult WT and HD mice. The data were obtained from digital images of 12 microscopic fields of 6 WT and 6 HD brain sections from 2 WT and
2 HD mice, which were treated under exactly the same conditions. The arbitrary units (A.U.) measured with NIH ImageJ were used for calculating
Mean±SD signal intensity per cell. Statistical significance was determined by two-tailed Student’s t-test using N=12 microscopic fields. D) Antibody
binding to detect cell surface GABAα1 in non-permeabilized brain sections. Brain sections were from the same mice as used for detecting Glut3
expression in A). Shown are images obtained with a SPOT camera. E) and F) Bar graphs show results for cross sectional areas and signal intensities of
GABAα1 positive neurons in the cortex A. Digital images were taken from 7 microscopic fields from 4 WT and 4 HD brain sections from 2 WT and 2
HD mice in (E) and for GABAα1 signal intensities in (F). Two sections of each animal were used for analysis. For each section, one or two microscopic
fields were selected. Error bars in both E and F represent standard deviations. Two-tailed Student’s t-test was performed to determine the statistical
significance using N= 7 microscopic fields.
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[33]. In agreement with this idea, primary HD
140Q/140Q cor-
tical neurons were impaired in taking up glucose, the first
step for neurons to utilize glucose. The findings in this
study show that rab11, which is known to have diminished
activity in HD cells, regulates the cell surface expression of
Glut3, the major transporter for glucose uptake in neurons.
Relative to WT neurons, HD
140Q/140Q neurons expressed
normal levels of Glut3 protein, but displayed less Glut3 on
the cell surface, suggesting that there is a deficit of Glut3
trafficking to the cell surface in HD neurons. Using an
antibody-binding assay to detect protein expression on
neuronal cell surfaces in non-permeabilized brain slices of
adult mice, we found that the defect of Glut3 trafficking
was also present in the brain of adult HD
140Q/140Q mice.
Our study suggests that a Glut3 trafficking deficit arising
from compromised activation of rab11 in HD neurons is a
cause of energy metabolism disturbance in HD.
The subcellular localization of Glut3 in neurons was not
formally investigated previously. In this study we found
that about 4% of Glut3 is located on the cell surface in pri-
mary cortical neurons. Ferreira et al. exploited a biotinyl-
ation assay similar to ours to investigate Glut3 localization
in rat cortical and hippocampal neurons [29]. Although
not specifically noted by the authors, a predominantly
intracellular localization of Glut3 in neurons is suggested
by their data, which revealed extremely low levels of Glut3
on neuronal surfaces at steady state [29]. The mainly
intracellular localization of Glut3 is also observed in plate-
lets [34]. However, in other cell types or in conditions of
overexpression Glut3 can locate mainly at plasma mem-
branes [12,35]. Why there exists a significant intracellular
pool of Glut3 in neurons is not clear. This intracellular
pool of Glut3 may allow neurons to quickly respond to
conditions demanding high-energy. Transient exposure of
cerebellar granule neurons to glutamate vastly increases
the expression of Glut3 on the cell surface without altering
total levels of Glut3 protein [36]. Stimuli that activate
NMDA receptors induce Glut3 translocation from intra-
cellular compartments to cell surfaces [29].
We found that Glut3 was co-localized with rab11 in
neurites and somata of primary cortical neurons and was
recovered in brain endosomes immuno-isolated using anti-
bodies specific for rab11. Viral expression of permanently
active or inactive rab11 respectively altered cell surface
expression of Glut3 with no effect on overall expression
levels of Glut3 protein. These data suggest that Glut3 in
neurons travels through rab11-positive endosomes. As has
been proposed for AMPA receptors in hippocampal neu-
rons [37], rab11-positive endosomes may serve as a reser-
voir for rapid delivery of Glut3 to the neuronal surface
in response to stimuli. It is also possible that rab11-
positive recycling endosomes act as a station where
Glut3 is sorted to its storage compartment in neurons, in
a way similar to the sorting of Glut4 to intracellular Glut4
storage compartments in adipocytes and muscle cells
[38-40]. Future studies are needed to investigate if such
specialized Glut3 storage compartments exist in neurons.
The importance of Glut3 is indicated by studies in
mice null for Glut3. Homozygous Glut3 deficient mice
die prenatally [41]. While they can survive, heterozygous
Glut3-deficient mice show brain developmental charac-
teristics seen in autism spectrum disorders such as
abnormal cognitive flexibility with intact motor ability,
perturbed social behavior with reduced vocalization and
stereotypies, and seizures [42]. We found that Glut3 ex-
pression on neuronal cell surfaces was reduced in brain
regions that are most affected in HD. It is conceivable
that in individuals with HD, a small decline in surface
expression of Glut3 occurring over decades could ad-
versely affect glucose uptake and brain function.
Conclusion
In conclusion, we identify Glut3 as a new cargo protein
that is regulated by rab11 during its trafficking to the
cell surface and show defective trafficking of Glut3 in
HD neurons. This Glut3 trafficking deficit is a result of
rab11 dysfunction in HD cells.
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